BVN | Ticker Profile - Titan Protect

BVN

Compañía de Minas Buenaventura S.A.A.

Basic Materials · Other Precious Metals & Mining · NYQ

$30.26

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$8.8B

Total market value of the company

Trailing P/E

10.49

Reasonably valued

Forward P/E

10.28

Based on estimated future earnings — lower means cheaper

Rev Growth

+103.0%

Year-over-year revenue change

Profit Margin

47.7%

How much profit the company keeps from each dollar of revenue

ROE

26.3%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$42.50

+40% from current price — median analyst estimate

Recommendation

NONE

Consensus view from 5 analysts covering this stock

About Compañía de Minas Buenaventura S.A.A.

Compañía de Minas Buenaventura S.A.A., together with its subsidiaries, engages in the exploration, development, construction, and operation of mines in Peru, the Americas, Europe, and Asia. It explores for gold, silver, copper, zinc, lead, and antimony deposits. The company also engages in the exploration, extraction, concentration, smelting, and marketing of polymetallic minerals and metals. In addition, it is involved in electricity transmission and generation; hydroelectric plant operation; and production of manganese sulfate monohydrate, as well as tailings dam management. The company was incorporated in 1953 and is based in Lima, Peru.

https://buenaventura.com

Country: Peru Industry: Other Precious Metals & Mining

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

1.065

Excellent risk-adjusted returns

Kelly Fraction

0.0754

Suggested allocation is meaningful — the edge justifies a position

Calmar Ratio

1.216

Returns exceed worst-case losses — strong risk profile

Annual Return

44.0%

Historical annualised return based on price data

Max Drawdown

-36.2%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.31

Very low correlation to market moves

52W High

$44.67

32% below the year high

52W Low

$14.80

104% above the year low

Avg Volume

1,487,170

Average daily shares traded — higher means easier to buy and sell

Short Ratio

3.3

Days it would take all short sellers to cover — higher means more crowded

Short % Float

2.9%

Low short interest — limited bearish positioning

Div Yield

328.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$3.30

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

16.28

Heavy leverage — higher financial risk if revenues decline

Current Ratio

1.84

Healthy liquidity position

Quick Ratio

1.69

Like current ratio but excludes inventory — stricter test

Gross Margin

58.9%

Revenue left after cost of goods — higher means pricing power

Operating Margin

52.6%

Profit from core operations before interest and tax

Free Cash Flow

$238M

Positive — the business generates more cash than it spends

Revenue (TTM)

$2.0B

Total revenue over the last 12 months

Net Income

$987M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$50.00

Target Median

$42.50

Target Low

$27.40

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go